Types, Trends, and Patterns of Reported Antimicrobial Errors in a Tertiary Care Hospital in Saudi Arabia

Background Antimicrobial medication errors (AMEs) pose critical threats to patient safety and fuel the global rise of antimicrobial resistance. This study retrospectively examines AMEs between 2022 and 2024 at a tertiary care hospital in Riyadh, Saudi Arabia, along with its affiliated community health centers. Objectives The study aimed to identify prescribing vulnerabilities, assess severity outcomes, and propose targeted interventions to enhance safety and stewardship practices. Methods This retrospective cohort study was employed to analyze AME, utilizing electronic health records, pharmacy databases, and institutional incident reporting systems reviewed by the Medication Safety Committee across the prescribing, transcribing, dispensing, and administration phases. Data were stratified by type, severity category, drug class, duration, location, and staff role with cross-validation through pharmacy audits. Results Prescribing errors consistently dominated across all 3 years, 71.4% (2022), 66.7% (2023), and 68.0% (2024), indicating entrenched clinical vulnerabilities. Dispensing errors steadily decreased over the study period, while supply and logistic errors spiked to 6.3% in 2023 before declining in 2024. Augmentin, cefazolin, azithromycin, amoxicillin, meropenem, and vancomycin were the most error-prone agents. Near-miss incidents (Category B) comprised the majority of reports, and hazardous conditions (Category A) rose notably in 2024. Multidisciplinary error reporting showed pharmacists and physicians as primary identifiers. The heatmap highlights declining errors in inpatient units, rising risks in community centers. Conclusion The analysis highlights persistent prescribing risks and emerging operational challenges in a tertiary care hospital’s antimicrobial management. Targeted education, enhanced digital systems, and site-specific interventions are essential for mitigating errors and aligning with global stewardship frameworks.

Authors

Institutions

Publication Details

Journal
International Journal of Pediatrics and Adolescent Medicine
Published
2025-09-01
DOI
https://doi.org/10.4103/ijpam.ijpam_148_25
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Types, Trends, and Patterns of Reported Antimicrobial Errors in a Tertiary Care Hospital in Saudi Arabia

Rana Hassan Almaghrabi, Yasmin Barnawi, Wafa Alfahad, Mahdi Ali Alanzi et al.
International Journal of Pediatrics and Adolescent Medicine
Pharmaceutical Practices and Patient Outcomes
article

Types, Trends, and Patterns of Reported Antimicrobial Errors in a Tertiary Care Hospital in Saudi Arabia

Rana Hassan Almaghrabi, Yasmin Barnawi, Wafa Alfahad, Mahdi Ali Alanzi, Hamdah Hameed Al Enazi, Amal Bin Akresh, Ruba Mohammed Bin Talib, Khulud Salem AlQahatani
article en

Abstract

Background Antimicrobial medication errors (AMEs) pose critical threats to patient safety and fuel the global rise of antimicrobial resistance. This study retrospectively examines AMEs between 2022 and 2024 at a tertiary care hospital in Riyadh, Saudi Arabia, along with its affiliated community health centers. Objectives The study aimed to identify prescribing vulnerabilities, assess severity outcomes, and propose targeted interventions to enhance safety and stewardship practices. Methods This retrospective cohort study was employed to analyze AME, utilizing electronic health records, pharmacy databases, and institutional incident reporting systems reviewed by the Medication Safety Committee across the prescribing, transcribing, dispensing, and administration phases. Data were stratified by type, severity category, drug class, duration, location, and staff role with cross-validation through pharmacy audits. Results Prescribing errors consistently dominated across all 3 years, 71.4% (2022), 66.7% (2023), and 68.0% (2024), indicating entrenched clinical vulnerabilities. Dispensing errors steadily decreased over the study period, while supply and logistic errors spiked to 6.3% in 2023 before declining in 2024. Augmentin, cefazolin, azithromycin, amoxicillin, meropenem, and vancomycin were the most error-prone agents. Near-miss incidents (Category B) comprised the majority of reports, and hazardous conditions (Category A) rose notably in 2024. Multidisciplinary error reporting showed pharmacists and physicians as primary identifiers. The heatmap highlights declining errors in inpatient units, rising risks in community centers. Conclusion The analysis highlights persistent prescribing risks and emerging operational challenges in a tertiary care hospital’s antimicrobial management. Targeted education, enhanced digital systems, and site-specific interventions are essential for mitigating errors and aligning with global stewardship frameworks.

International Journal of Pediatrics and Adolescent MedicineVol. 12(3)
Riyadh Armed Forces Hospital (SA), Office of Infectious Diseases (US), Pediatric Infectious Diseases Society (US)
Openalex Percentile: Top 72%
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.